Journal of Advanced Pharmaceutical Science and Technology

Submit Manuscript

Editorial stewardship · JAPST

For Editors

JAPST editors assess scope and readiness, select qualified reviewers, interpret evidence and recommendations, and protect the independence of each decision.

Role
Editorial assessment
Reviewers
Normally at least two
Default
Single-blind
Escalation
Editorial office

Release profile

JAPST · Pharmaceutical science, technology and practice
01

Before accepting an assignment

Accept only when subject expertise, time, confidentiality and conflict requirements can be met.

Expertise and availability

  • Confirm that the manuscript falls within the editor's relevant expertise
  • Review the invitation deadline and decline promptly when it cannot be met
  • Protect the manuscript and correspondence as confidential material
  • Use unpublished information only for the assigned evaluation

Conflicts and recusal

Disclose personal, professional, financial, institutional, collaborative, competitive and supervisory conflicts. Decline when impartial handling is not possible.

An editor does not handle the editor's own manuscript. Another qualified editor manages reviewer selection and the decision independently. Editorial service confers no advantage in review or acceptance.

02

Screening and reviewer selection

External review begins only after the editor confirms scope, completeness and minimum ethical and reporting requirements.

Initial assessment

  • Confirm the contribution fits the Aims and Scope; pharmacology, natural products, medicine safety and pharmacy-practice studies do not require formulation innovation
  • Check article type and required sections
  • Assess whether methods and evidence support meaningful review
  • Identify immediate ethics, authorship, data or image concerns

Reviewer selection

  • Select independent subject-matter experts with appropriate methods knowledge
  • Check institutional, collaborative and competitive conflicts
  • Avoid relying on author suggestions without independent assessment
  • Replace reviewers when reports are conflicted, superficial or inappropriate
Review model

Peer review: Single-blind by default; double-blind review is available on request.

Manuscripts that proceed to external peer review are normally evaluated by at least two independent subject-matter experts.

When double-blind review is requested, editors must ensure that author-identifying information is not shared with reviewers.

03

Evaluation, revision and decision

Reviewer recommendations inform but do not replace the editor's independent assessment.

Read the evidence

Assess methods, controls, analysis, reporting, limitations and pharmaceutical relevance.

Evaluate reports

Resolve conflicting or incomplete reviews and seek additional expertise when needed.

Set revision requirements

Separate essential scientific changes from optional suggestions and define a clear response.

Document the decision

State the rationale and ensure it follows journal policies and the evidence in the record.

Decision criteria

Editorial decisions are based on scope, scientific quality, methodological rigor, ethical compliance, reporting quality, and relevance to the journal.

04

Research-integrity and Special Issue handling

Editors should preserve evidence, avoid independent investigation beyond their role and escalate concerns confidentially.

Escalate concerns

  • Potential plagiarism, fabrication or image manipulation
  • Unreported conflicts, sponsor influence or authorship disputes
  • Ethics, consent, trial-registration or animal-welfare concerns
  • Material or data provenance that cannot be established
  • Post-publication errors requiring correction or further action

Send the evidence and editorial record to [email protected].

AI and confidentiality

Editors must not upload confidential manuscripts, figures, data or personal information to an AI service where confidentiality cannot be assured. AI cannot replace editorial judgment.

Special Issues

Guest editors work within the approved collection scope but follow the journal's normal review, conflict, recusal, integrity and final-decision safeguards.

05

Editorial appointment and support

Editorial appointments are vetted for current, on-scope expertise and do not arise from account registration alone.

Appointment evidence

The editorial office reviews a current CV or publication record, ORCID iD, affiliation and demonstrated expertise relevant to the journal's pharmaceutical science, technology and practice scope.

Editors should keep their profile, affiliation, expertise and conflict information current and contact the office when an assignment or policy question requires support.

Contact the editorial office

Send assignment, conflict, integrity or policy questions to the JAPST editorial office.

Email editorial support

Menu